Intelligent Bio Solutions
INBS
8 hedge funds and large institutions have $606K invested in Intelligent Bio Solutions in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
1.09% less ownership
Funds ownership: 2.1% → 1.01% (-1.1%)
38% less funds holding
Funds holding: 13 → 8 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
76% less capital invested
Capital invested by funds: $2.52M → $606K (-$1.91M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$215K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$20.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$77 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$527K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$457K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$72.7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$62.6K |
| 5 |
VF
Virtu Financial
New York
|
-$53K |
INBS Hedge Fund Activity: Q2 2024 in Review
8 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q2 2024, worth a combined $606K — down 76% from $2.52M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of INBS and 2 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $215K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $527K sold.
- 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q2 2024, down from 13 in Q1 2024.
- Funds reported $606K of Intelligent Bio Solutions stock for Q2 2024, down 76% quarter-over-quarter.
- 2 funds opened new Intelligent Bio Solutions positions in Q2 2024 and 7 closed out, a net change of -5 holders.
- The largest Intelligent Bio Solutions buyer in Q2 2024 was Altium Capital Management, an estimated $215K added.
- The largest Intelligent Bio Solutions seller in Q2 2024 was Alyeska Investment Group, an estimated $527K sold.
Based on aggregated 13F filings for Q2 2024.